Share Based Compensation (Tables)

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The assumptions used to value SARs granted in 2021 are as follows:

	2021 grant with 7 year expiration		2021 grant with 5 year expiration
Risk-free interest rate	1.06	%	0.74	%
Expected dividend yield	3.00	%	3.00	%
Expected common stock volatility	55.59	%	55.59	%
Expected life	7 years		5.5 years

Share-based Payment Arrangement, Option, Activity

A summary of our SAR and stock option activity during the first nine months of 2021 and 2020 is as follows:

	For the Nine Months Ended September 30,
	2021
	Options/SARs	Aggregate Intrinsic Value (in thousands)		Remaining Contractual Term (Yrs.)	Weighted-Average Exercise Price
Outstanding, January 1	329,203				$	20.47
Granted	177,489				21.85
Exercised	(5,800)				3.85
Forfeited	—				—
Expired	—				—
Outstanding, September 30	500,892	$	1,808	7.12	$	21.15
Exercisable, September 30	213,216	$	1,287	5.00	$	18.90

	For the Nine Months Ended September 30,
	2020
	Options/SARs	Aggregate Intrinsic Value (in thousands)		Remaining Contractual Term (Yrs.)	Weighted-Average Exercise Price
Outstanding, January 1	330,703				$	20.44
Granted	—				—
Exercised	—				—
Forfeited	—				—
Expired	—				—
Outstanding, September 30	330,703	$	349	6.58	$	20.44
Exercisable, September 30	179,375	$	349	5.52	$	17.03

Share-based Payment Arrangement, Restricted Stock Unit, Activity

	RSUs	Weighted Average Grant Date Fair Value
Nonvested, December 31, 2020	15,686	$	20.40
Granted	—	—
Forfeited	—	—
Vested	(3,400)	19.61
Nonvested, September 30, 2021	12,286	$	20.62

	RSUs	Weighted Average Grant Date Fair Value
Nonvested, December 31, 2019	2,892	$	25.93
Granted	12,841	18.19
Forfeited	—	—
Vested	(651)	25.60
Nonvested, September 30, 2020	15,082	$	20.45